baber/WOPTO huggingface dataset:
Patent EP-1471668-B1 (EP)
Title: Egaliseur de dispersion et procede d'egalisation de dispersion
Inventor: SUGIHARA TAKASHI
IPC: H04B10/077
Filed: 2003-01-27
Granted: 2012-06-27
Abstract: Selon l'invention, lorsqu'aucune information d'alarme ne parvient à un récepteur optique (12), à un décodeur de code à correction aval (13) et à un moniteur de signal client (14), un circuit de commande (15) utilise une information de comptage de correction d'erreur, acquise par le décodeur de code à correction aval (13) afin de commander un égaliseur de dispersion variable (11) de façon que l'erreur d'émission soit plus faible, et fixe une valeur d'égalisation de dispersion lorsqu'une erreur diminue en dessous d'une valeur déterminée. Lorsqu'une information d'alarme est reçue, le circuit de commande fait passer la commande normale de l'égaliseur de dispersion variable (11) en commande de mode de recherche afin de rechercher une valeur d'égalisation de dispersion optimale sur un large domaine afin de rechercher cette valeur à une vitesse plus élevée.
Patent EP-1554381-B1 (EP)
Inventor: PRYDZ HANS PETER B
IPC: C12N15/11
Filed: 2003-02-06
Granted: 2009-11-25
Abstract: The present invention relates to synthesised RNAs, more specific short interfering RNAs (siRNAs) that are able to modulate the expression of Tissue Factor (TF), as well as to a pharmaceutical preparation comprising the synthesised siRNA(s) and use thereof.
Patent EP-1476514-B1 (EP)
Inventor: HARDIN JOHN M
IPC: B41M5/382
Filed: 2003-02-21
Granted: 2009-07-22
Abstract: There is described a protective overcoat material comprising from about 40 weight percent to about 85 weight percent of poly(methyl methacrylate) having a Tg above about 100° C., from about 10 weight percent to about 50 weight percent of poly(ethyl methacrylate) having a Tg of from about 52° C. to about 65° C. and about 1 weight percent of a melt flow modifier. Also described are thermal image recording members which include a protective overcoat layer.
Patent EP-1504918-B1 (EP)
Inventor: YUKAWA SHIGEO
IPC: B41M5/00
Filed: 2003-05-12
Granted: 2009-03-04
Abstract: A laminate for printing for coloring a resin layer by allowing a sublimable dyeing agent to permeate into the inside of the resin layer through heating, which comprises, in the order from the surface, a surface resin layer A (1) having a weak affinity with the sublimable dyeing agent and allowing the dyeing agent to pass through it and a coloring resin layer B (12) having strong affinity with the dyeing agent and preventing the transfer of the dyeing agent; and a printing method and a printed matter using the laminate. The laminate for printing has, formed as an inner layer, a coloring resin layer having strong affinity with a sublimable dyeing agent and capable of preventing the transfer of the dyeing agent, which allows the prevention of the transfer of a sublimable dyeing agent having been printed. <IMAGE>
Patent EP-1509419-B1 (EP)
Inventor: STEEN MARCUS
IPC: B60W10/06
Filed: 2003-05-08
Granted: 2011-01-26
Abstract: A motor vehicle with a clutch (3) and an automated transmission (9) between the engine and the drive wheels of the vehicle. The vehicle has control elements (45,48) for engine function and transmission function depending on a set position of an electronic gear selector (46). The control elements, with the gear selector in its position for automatic shifting, selects a gear for starting off or under way, which is determined by the gear selection strategy stored in the control means as a function of various parameters fed into the control elements. The control elements, are arranged to perform, firstly, a simulation process related to the gear selection strategy with at least one alternative set of parameters (U2-UN) and, secondly; a comparative analysis based on a first set of control parameters (U1).
Patent EP-1505508-B1 (EP)
Inventor: KATAYAMA YASUSHI
IPC: G06F12/00
Filed: 2003-05-07
Granted: 2012-08-22
Abstract: L'invention concerne un système de stockage réparti comprenant n noeuds (201, 202 20n); un dispositif de commande d'enregistrement (10) conçu pour commander et réguler les enregistrements de données dans les noeuds; et un dispositif de commande de transmission (30) conçu pour lire les données enregistrées dans les noeuds, lesquels noeuds sont reliés par l'intermédiaire d'un réseau. Le dispositif de commande d'enregistrement (10) soumet les données consistant en p blocs à un codage FEC dont le rapport de codage est q/p, ce qui permet de produire des données consistant en q blocs. Ensuite, le dispositif de commande d'enregistrement (10) ajoute à ces données une probabilité d'enregistrement alpha enregistrée par un noeud, et la transmet sur le réseau. Pendant la lecture, le dispositif de commande de transmission (30) envoie, en réponse, les données auxquelles on a ajouté une probabilité de réponse bêta pour l'exécution de la réponse aux données.
Patent EP-1549340-B1 (EP)
Inventor: HOLMGREN JAN
IPC: A61K/
Filed: 2003-06-05
Granted: 2008-12-24
Abstract: A bifunctional composition comprising an intracellularly effective immunomodulating nucleic acid component containing at least one immunostimulatory, immunoinhibitory or immunomodulating motif and selected from a mononucleotide, a dinucleotide, an oligonucleotide or a polynucleotide with either a natural phosphodiester backbone or a modified backbone, optionally in combination with a specific antigen, in association with a protein binding to specific receptors on mammalian cell surfaces selected from the group consisting of cholera toxin (CT), the subunit B of CT (CTB), Escherichia coli heat labile enterotoxin (LT), the subunit B of LT (LTB), and proteins or protein derivatives that react with antiserum to CT or LT, bind to GM1 ganglioside, ADP-ribosylates an acceptor protein, or give rise to accumulation of cyclic AMP in target cells, and antibodies or other proteins which after binding to a specific cell surface component can be internalized into the cell, is described. The composition is useful for treatment of tumors, infections, graft rejections, immunosuppressive states, autoimmune diseases and allergies, and further with a specific antigen it is useful for immunoprophylaxis, immunotherapy or induction of tolerance, and for treatment ex vivo of an antigen-presenting cell for subsequent infusion into a mammal for vaccination or immunotherapy purposes.
Patent EP-1496750-B1 (EP)
Inventor: ZACHARIASSEN JORGEN
IPC: A22C21/04
Filed: 2003-04-16
Granted: 2007-08-15
Abstract: A method and an apparatus for scalding of slaughtered poultry are described, for example chickens, hens, turkeys, ducks, or geese, prior to plucking thereof, where the birds while shackled by their feet are conveyed through a scalding chamber (2), preferably via a sluice device, in which chamber a precisely controlled heated atmosphere of humid, hot air is established by blowing in steam at the bottom of the scalding chamber, which air is recirculated and blown directly onto the poultry, and where the scalding period is determined by the length and course of the conveyor (8) and by the capacity and/or speed of the conveyor, where a scalding chamber (2) with a relatively large height is used, and where the scalding chamber conveyor (8) including its secondary nozzles (10) extends through two or more levels (stories).
Patent EP-1549639-B1 (EP)
Inventor: FORBES IAN THOMSON
IPC: C07D417/14
Filed: 2003-10-06
Granted: 2006-05-24
Abstract: The invention provides compounds of formula (I): wherein A and B represent the groups -(CH<SUB>2</SUB>)<SUB>m</SUB>- and -(CH<SUB>2</SUB>)<SUB>n</SUB>- respectively; R<SUP>1 </SUP>represents hydrogen or C<SUB>1-6</SUB>alkyl; R<SUP>2 </SUP>represents hydrogen, halogen, hydroxy, cyano, nitro, hydroxyC<SUB>1-6</SUB>alkyl, trifluoromethyl, trifluoromethoxy, C<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkoxy, C<SUB>1-6</SUB>fluoroalkoxy, -(CH<SUB>2</SUB>)<SUB>p</SUB>C<SUB>3-6</SUB>cycloalkyl, -(CH<SUB>2</SUB>)<SUB>p</SUB>OC<SUB>3-6</SUB>cycloalkyl, -COC<SUB>1-6</SUB>alkyl, -SO<SUB>2</SUB>C<SUB>1-6</SUB>alkyl, -SOC<SUB>1-6</SUB>alkyl, -S-C<SUB>1-6</SUB>alkyl, -CO<SUB>2</SUB>C<SUB>1-6</SUB>alkyl, -CO<SUB>2</SUB>NR<SUP>5</SUP>R<SUP>6</SUP>, -SO<SUB>2</SUB>NR<SUP>5</SUP>R<SUP>6</SUP>, -(CH<SUB>2</SUB>)NR<SUP>5</SUP>R<SUP>6</SUP>, -(CH<SUB>2</SUB>)<SUB>p</SUB>NR<SUP>5</SUP>COR<SUP>6</SUP>, optionally substituted aryl ring, optionally substituted heteroaryl ring or optionally substituted heterocyclyl ring; R<SUP>3 </SUP>represents hydrogen, halogen, hydroxy, cyano, nitro, hydroxyC<SUB>1-6</SUB>alkyl, trifluoromethyl, trifluoromethoxy, C<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkoxy, C<SUB>1-6</SUB>fluoroalkoxy, -(CH<SUB>2</SUB>)<SUB>p</SUB>C<SUB>3-6</SUB>cycloalkyl, -(CH<SUB>2</SUB>)<SUB>p</SUB>OC<SUB>3-6</SUB>cycloalkyl, -COC<SUB>1-6</SUB>alkyl, -SO<SUB>2</SUB>C<SUB>1-6</SUB>alkyl, -SOC<SUB>1-6</SUB>alkyl, -S-C<SUB>1-6</SUB>alkyl, -CO<SUB>2</SUB>C<SUB>1-6</SUB>alkyl, -CO<SUB>2</SUB>NR<SUP>7</SUP>R<SUP>8</SUP>, -SO<SUB>2</SUB>NR<SUP>7</SUP>R<SUP>8</SUP>, -(CH<SUB>2</SUB>)<SUB>p</SUB>NR<SUP>7</SUP>R<SUP>8 </SUP>or -(CH<SUB>2</SUB>)<SUB>p</SUB>NR<SUP>7</SUP>COR<SUP>8</SUP>; R<SUP>4</SUP>represents hydrogen, hydroxy, C<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkoxy, C<SUB>1-6</SUB>fluoroalkoxy, trifluoromethyl, trifluoromethoxy, halogen, -OSO<SUB>2</SUB>CF<SUB>3</SUB>, -(CH<SUB>2</SUB>)<SUB>p</SUB>C<SUB>3-6</SUB>cycloalkyl, -(CH<SUB>2</SUB>)<SUB>q</SUB>OC<SUB>1-6</SUB>alkyl or -(CH<SUB>2</SUB>)<SUB>p</SUB>OC<SUB>3-6</SUB>cycloalkyl; R<SUP>5 </SUP>and R<SUP>6 </SUP>each independently represent hydrogen, C<SUB>1-6</SUB>alkyl or, together with the nitrogen or other atoms to which they are attached, form an azacycloalkyl ring or an oxo-substituted azacycloalkyl ring; R<SUP>7 </SUP>and R<SUP>8 </SUP>each independently represent hydrogen or C<SUB>1-6</SUB>alkyl; m and n independently represent an integer selected from 1 and 2; p independently represents an integer selected from 0, 1, 2 and 3; q independently represents an integer selected from 1, 2 and 3; or a pharmaceutically acceptable salt or solvate thereof, with the proviso that the compounds 8-hydroxy-3-methyl-7-phenylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine, 8-hydroxy-7-4-(hydroxyphenyl)sulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine, 7-phenylsulfonyl-1,2,3,4-tetrahydroisoquinoline and 7-phenylsulfonyl-1,2,3,4-tetrahydroisoquinoline hydrochloride are excluded. The compounds are useful in therapy, in particular as antipsychotic agents.
Patent EP-1519977-B1 (EP)
Inventor: SRINIVASAN VEERARAGHAVAN
IPC: C08G63/64
Filed: 2003-05-28
Granted: 2007-03-07
Abstract: Polyestercarbonates are disclosed which comprise structural units derived from at least one bisphenol derived from terpene precursors, at least one aromatic dihydroxy compound comonomer, at least one diester derived from a C1-C40 linear or branched divalent hydrocarbyl radical, and at least one carbonic acid diester. Also disclosed are methods to make the polyestercarbonates and articles derived therefrom.
Patent EP-1545594-B1 (EP)
Inventor: MARCH JOHN BERNARD
IPC: A61K39/12
Filed: 2003-10-02
Granted: 2009-11-25
Abstract: The present invention relates to vaccines comprising a bacteriophage which has been engineered to express an immunogenic protein/peptide and wherein the surface of the bacteriophage has not been modified to contain proteins/peptides designed to target the phage to receptors on the surface of specific cell types.
Patent EP-1575743-B1 (EP)
Inventor: HAYWARD PETER JAMES
IPC: B27M1/08
Filed: 2003-12-17
Granted: 2008-07-16
Abstract: The present invention relates to a method of using triadimefon and/or triadimenol as a preservative for the protection of glued wood-based products against attack and destruction of microorganisms, especially where the triadimefon and/or triadimenol is applied during the manufacturing process of the glued wood-based products. The invention further relates to a preservative composition for the protection of glued wood-based products including triadimefon and/or triadimenol and articles having such compositions as a part the article.
Patent EP-1585674-B1 (EP)
Inventor: STEVENS GERARD
IPC: B65D75/32
Filed: 2003-08-19
Granted: 2009-06-17
Abstract: A device for dislodging tablets from the interior of a blister comprises a cup having a circular side wall which can be comfortably gripped in the hand. The interior of the cup is provided with a central upward projection which extends above the cup side wall and has its free end shaped to rupture easily a foil backing to the blister so that the tablets can be dislodged from the blister by twisting the cup and fall into the cup from which they are readily recovered.
Patent EP-1570592-B1 (EP)
Inventor: KARABINIS PETER D
IPC: H04B7/185
Filed: 2003-08-15
Granted: 2008-01-23
Abstract: The capacity of a terrestrial wireless communications system that uses a terrestrial frequency band for communications with wireless terminals is expanded by utilizing a satellite frequency band for terrestrially receiving terrestrial communications from the wireless terminals. Since the wireless terminals are configured to transmit communications to a space-based component such as a satellite via a satellite frequency band, these transmissions also may be picked up (received) terrestrially. Thus, terrestrial base stations can be equipped with satellite frequency band receivers that can receive communications from the wireless terminals over a satellite frequency band. By using the satellite frequency band receiver in a terrestrial base station, additional capacity and/or quality of service may be provided for a terrestrial and/or satellite communications system.
Patent EP-1413509-B1 (EP)
Title: Bicycle hub transmission
Inventor: SHOGE AKIHIKO
IPC: B62M9/12
Filed: 2001-03-09
Granted: 2005-12-28
Abstract: A bicycle hub transmission is provided comprising a power transmission mechanism (82) disposed between a driver (70) and a hub shell (74) for communicating rotational power from the driver (70) to the hub shell (74) through a plurality of power transmission paths. The power transmission mechanism includes a first planet gear carrier (550) and a clutch ring (562) engageable with the driver (70) and the first planet gear carrier (550). A coaster brake is provided for retarding rotation of the hub shell when reverse rotational power is supplied to the driver (70). The clutch ring (562) is adapted to disengage from the first planet gear carrier (550) when the driver (70) is rotated in reverse for braking. <IMAGE>
Patent EP-1564302-B1 (EP)
Inventor: LIN SHIU-RU
IPC: C12Q1/68
Filed: 2004-02-13
Granted: 2011-09-14
Abstract: This invention relates to provide the genes for diagnosing colorectal cancer, the gene sequences searching comprise the steps of: (1) deriving epithelium cells from normal intestines, polypus of intestines and colorectal cancer tissue; (2) collecting genes with highly differential gene expression by Suppression Subtractive Hybridization (SSH), and building library; (3) deriving colonies with relatively high signal intensities from cancer tissue; (4) collecting more clinically cancer tissues by Northern Hybridization, real-time Polymerase Chain Reaction (PCR) combined with analysis of bioinformation to affirm variation between differential gene expression; and (5) selecting the most suitable genes from said library, and using the gene sequence as reagent provides the effects of early diagnosis, specificity, highly sensitivity and safety.
Patent EP-1459656-B1 (EP)
Inventor: GREGER JEFF G
IPC: A63G9/00
Filed: 2003-11-26
Granted: 2008-05-14
Abstract: A child swing (1) includes a frame (10), a seat (20) including a seat back (22), and at least one hanger arm (30;530) that connects the seat (20) to the frame (10). <IMAGE>
Patent EP-1630232-B1 (EP)
Inventor: SEEGERT DIRK
IPC: C12N15/67
Filed: 2004-08-27
Granted: 2008-07-02
Abstract: Described are codon optimized sgp130 encoding nucleic acid molecules as well as a method for the highly efficient recombinant production of sgp130 in mammalian cells or bacteria using a nucleic acid molecule of the invention.
Patent EP-1502586-B1 (EP)
Inventor: FLEISCHER WOLFGANG
IPC: A61K45/08
Filed: 2000-05-25
Granted: 2006-09-27
Abstract: Use of an anti-inflammatory agent, such as povidone iodine for the preparation of a pharmaceutical composition for the treatment of diseases in the interior of the human or animal body which are succeptible to the administration of such agents.
Patent EP-1538302-B1 (EP)
Inventor: BEHNEN GEREON
IPC: E21D9/13
Filed: 2004-11-26
Granted: 2010-04-28
Abstract: Process for filling or pressing hollow chambers outside light tunnel tubes or a tunnel comprises using dissolved ground material or a ground mixture produced during degradation. Preferred Features: The ground material or a ground mixture is prepared within the tunnel tubes for the purpose of filling or pressing.
Patent EP-1541218-B1 (EP)
Inventor: CHIANG ROBERT LING
IPC: C01B23/00
Filed: 2004-12-07
Granted: 2006-08-09
Abstract: This invention relates to an improvement in a process for removing water from a hydride gas, and particularly ammonia, by contacting the hydride gas with a drying agent under conditions for effecting removal of the water. The improvement for significantly reducing the water content to trace levels in said hydride gas resides in the use of at least Group 1 metal oxide and at least one Group 2 metal oxide as a drying agent.
Patent EP-1452531-B1 (EP)
Inventor: WILLIAMS ALVIN SCOTT
IPC: A61K8/00
Filed: 2004-02-16
Granted: 2005-12-28
Abstract: The present invention relates to the perfume industry. It concerns more particularly a compound of formula <CHEM> wherein R represents a linear, branched or cyclic C1-3 hydrocarbon group, and the wavy line indicates that the substituents on the epoxide moiety may have a cis or trans configuration, or a mixture of compounds of formula (I). The compounds of formula (I), or a mixture thereof, are useful as perfuming ingredients.
Patent EP-1468911-B1 (EP)
Inventor: TJIPTAHARDJA TISNA
IPC: F28D15/04
Filed: 2004-02-20
Granted: 2006-04-05
Abstract: The satellite has a structure (6) including a north face and a south face oriented perpendicular to an earth rotational axis. The structure has an east face and a west face exposed periodically to solar radiation during rotation of satellite. The structure has a rack that supports electronic equipment and includes a fluid loop transferring heat emitted by the equipment towards panel radiators disposed at the respective faces. The fluid loop includes evaporators in thermal contact with each of the faces.
Patent EP-1544474-B1 (EP)
Title: Radial pump
Inventor: ATSCHREITER FRIEDRICH
IPC: F04D15/00
Filed: 2004-12-16
Granted: 2007-02-14
Abstract: The radial pump, especially a cooling medium pump for an internal combustion engine has at least one first group (5) of impeller blades (6) pivotable around axes (9) parallel to the impeller axis. The group of pivotable impeller blades is located in the region of the flow outlet (22). The group of pivotable impeller blades are automatically pivotable in dependence upon the rotational speed. The pivotable blades are pivot-mounted in the region of the flow outlet side ends of fixed impeller blades (4).
Patent EP-1601638-B1 (EP)
Inventor: FISCHER ROLF-HARTMUTH
IPC: C07C45/48
Filed: 2004-02-26
Granted: 2006-12-27
Abstract: La présente invention concerne un procédé de fabrication de cyclopentanone très pur, ainsi que l'utilisation d'oxydes d'alcalis sur des supports oxydiques pour la fabrication de cyclopentanone.
Patent EP-1603941-B1 (EP)
Inventor: JAY DANIEL G
IPC: C12N15/10
Filed: 2004-03-09
Granted: 2011-01-05
Abstract: The present invention describes the inhibitors of extracellular Hsp90. The inhibition of extracellular Hsp90 leads to a reduction of the invasiveness of the tumor cells. Furthermore, the invention relates to the use of molecules inhibiting extracellular Hsp90 function for the manufacture of a medicament for the treatment or prevention of invasion and/or metastatic potential of cancer cells.
Patent EP-1613185-B1 (EP)
Inventor: FENZI ROBERTO
IPC: A43B7/34
Filed: 2004-04-14
Granted: 2008-07-02
Abstract: A textile structure resistant to perforation, specifically for shoe soles, comprises one or more layers of woven fabric of aramidic fibers and one or more layers of woven fabric of high tenacity non-aramidic fibers; the layers are bonded together by means of thermoplastic film and each separate layer of fabric is treated, preferably ably in the right side, by coating with a polyester and/or acrylic resin enriched with powders of hard and abrasive materials, such as ceramic materials preferably micronized and in the form of aluminum silicates.
Patent EP-1659945-B1 (EP)
Inventor: NAESLUND INGEMAR
IPC: A61B6/04
Filed: 2004-08-12
Granted: 2009-07-01
Abstract: Patient repositioning device ( 10 ) comprising, a patient supporting panel ( 20 ), at least one pair of laterally adjustable side support structures ( 30 a,b, 40 a,b) for sideways supporting a patient ( 50 ) on the supporting panel ( 20 ). To achieve repeatable repositioning of a patient body ( 50 ) each pair of side support structures ( 30 a,b, 40 a,b) are linked by a link arrangement ensuring that the side support structures ( 30 a, b, 40 a, b) automatically are centered about a longitudinal axis (A-A) of the supporting panel ( 20 ) indicating the centre of a patient ( 50 ) supported on the panel ( 20 ). There is also provided a method of repositioning a patient.
Patent EP-1609189-B1 (EP)
Inventor: CONGER STEVEN
IPC: H02S30/20
Filed: 2004-03-19
Granted: 2011-06-15
Abstract: Systems and methods for disposing and supporting a solar panel array are disclosed. In one embodiment, a system for supporting a solar panel array includes the use of support columns and cables suspended between the support columns, with the panels received by solar panel receivers that are adapted to couple to the cables. The solar panel array may then be used to provide power as well as shelter. Cooling, lighting, security, or other devices may be added to the solar panel array.
Patent EP-1789174-B1 (EP)
Inventor: FRASER KEVIN S
IPC: B01J19/02
Filed: 2004-09-01
Granted: 2010-06-09
Abstract: A composite sparger for use in elevated temperature and corrosive environments. The composite sparger is formed from a thermally conductive non-combustible metal substrate. The surfaces of the conductive non-combustible metal exposed to the reactor environment are protected with a corrosion resistant layer. The corrosion resistant layer protects the substrate material from the corrosive environment of the reactor vessel and the substrate material conducts heat away from the corrosion resistant layer to prevent combustion of the corrosion resistant layer. The substrate material and corrosion resistant material may be selected so as to provide for sufficient thermal conduction to prevent combustion of the corrosion resistant material.
Patent EP-1660547-B1 (EP)
Inventor: GUZMANN MARCUS
IPC: C11D3/37
Filed: 2004-07-15
Granted: 2007-03-21
Abstract: Copolymers of (A1) 70 to 100 mol % of at least two different monoethylenically unsaturated carboxylic acid monomers and (A2) 0 to 30 mol % of one or more nonionic monomers, which have been reacted with (B) 5 to 30 mol %, based on the amidatable functional groups present in the copolymer of the monomers (A1) and if desired (A2), of an amino-C<SUB>1</SUB>-C<SUB>2</SUB>-alkanesulfonic acid and/or a salt thereof, and the preparation of the copolymers and their use in detergents, cleaners and rinse aids.
Patent EP-1691639-B1 (EP)
Title: Epilator
Inventor: GRIESHABER FRIEDER
IPC: A45D26/00
Filed: 2004-09-03
Granted: 2009-06-03
Abstract: The invention is directed to an epilator apparatus for the removal of hair. The epilator apparatus comprises a tape, which adheres to the hairs as the apparatus is moved relative to the skin. The motion of the apparatus relative to the skin feeds the tape into the plucking zone where the tape with the hairs adhered thereto is redirected perpendicular to the skin. This redirection results in the hairs being plucked from the skin as the epilator apparatus is advanced.